Kortemme: How AI Can Help Us Make New Medicines Faster

Department of Bioengineering and Therapeutic Sciences Professor Tanja Kortemme, PhD, is leading groundbreaking efforts at UCSF to harness artificial intelligence for the design of entirely new proteins — with the potential to revolutionize how we treat diseases like cancer, diabetes, and Alzheimer’s.  

In a Q&A from UCSF Magazine, our vice dean of research explains how decades of federally funded research, along with UCSF’s collaborative, interdisciplinary culture, are accelerating the creation of AI-generated proteins that could become the next generation of medicines. 

More 

Tags

Sites:
School of Pharmacy, Department of Bioengineering and Therapeutic Sciences

About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.